Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Biomedical Investments
AddedFeb 16, 2024
UpdatedJun 28, 2026
Biomedical Investments

Biomedical Investments

Israeli-based BMI invests in healthcare startups with breakthrough tech in emerging therapeutic segments.

HQ
Tel Aviv, Tel Aviv District, IL
Founded
1997
Overview
Compare
Employees

Biomedical Investments (BMI) is an Israeli-based private investment firm specializing in healthcare, particularly medical devices and biotechnology. The company focuses on startups with breakthrough technologies in emerging therapeutic segments, aiming to drive innovation in the healthcare industry.

Key achievements include significant investments from notable figures and organizations such as Mr. Leonard Abramson and Teva Pharmaceuticals. BMI's strategic investments have facilitated advancements in medical technology, contributing to the growth and success of numerous healthcare startups.

Biomedical Investments - Similar Companies

AshHill Biomedical logo

AshHill Biomedical

Amit Technion logo

Amit Technion

Arkin Bio Ventures logo

Arkin Bio Ventures

arkinholdings.com

Commerce Health Ventures logo

Commerce Health Ventures

Ventura BioMed Investors logo

Ventura BioMed Investors

ventura-biomed.com

Medvest logo

Medvest

medvest.co.uk

Biomedical Investments - Quick Facts

Who are Biomedical Investments' competitors?

Companies similar to Biomedical Investments include AshHill Biomedical, Amit Technion, Arkin Bio Ventures and Commerce Health Ventures.

When was Biomedical Investments founded?

Biomedical Investments was founded in 1997.

Where is Biomedical Investments' headquarters located?

Biomedical Investments' headquarters is located in Tel Aviv, Tel Aviv District, IL.

How many employees does Biomedical Investments have?

Biomedical Investments has 5 employees as of Feb 4, 2024.